The recent editorial by Dr. John Laragh (CIRCULATION 44: 971, 1971) was extremely enlightening in helping to decipher the puzzles of essential hypertension. There is no doubt that essential hypertension is composed of various subgroups, which when delineated will help to identify the person who is destined to have a benign or a progressively deteriorating clinical course. Some of the conclusions, however, need clarification. Numerous studies have documented the increased incidence of low-renin essential hypertension in Negroes.l 2 It is also a widely held belief that hypertension occurs at an earlier age and is more severe in Negroes.3 4 How can these views be reconciled with this editorial?
What was the proportion of Negroes in the study5 that Dr. Laragh referred to?
Since the study on which Dr. Laragh based his comments was apparently retrospective, the hazards of using low renin as a prognosticator of cardiovascular disease is readily apparent. Also, Brunner et al. did not mention in their abstract the period of follow-up of their patients nor whether these measurements were repeated over a period of time. The hazards of drawing firm conclusions from the small numbers of morbid events (four strokes and two myocardial infarctions in the normal-renin group versus none in the low-renin group) in this study are also obvious. Until further studies corroborate these findings, it appears premature to designate low-renin hypertension a benign condition.
The studies of Freis6 have documented the beneficial effects of antihypertensive therapy in a randomized sample of patients with hypertension. First of all, I should state that our study is not entirely retrospective so that about a third of the cardiovascular complications (strokes and heart attacks) occurred after our initial evaluation.
Nonetheless, despite a high degree of statistical significance, we heartily agree that prospective studies and larger numbers are needed to confirm our impression. I might add, however, that the numbers of patients in our study are of the same general order as those in the study by Freis which Dr. Mroczek cites. Data from our 219 patients will be described in detail in a paper to appear very soon. We hope that these data wvill provide a basis for defining further the nonhomogeneity of so-called "essential" hypertension and for permitting more specific, individualized treatment programs.
The high incidence of Blacks in the low-renin hypertension group does seem to present a paradox. That low-renin essential hypertension previously, and in our study, has been found to be relatively common in black populations seems difficult to reconcile with the high incidence of malignant and severe hypertension in Blacks. Also strokes and heart attacks are certainly wellrecognized complications of hypertensive disease in black populations. The answer to this seeming paradox may lie in the fact that hypertension in toto is much more common in the black population. Indeed, in a recent report by Finnerty the black population in the inner city of Washington had an approximately 50% incidence of hypertension. 
